Pain News and Research

Latest Pain News and Research

New risk-evaluation protocol can help emergency departments evaluate chest-pain patients

A recently developed risk-evaluation protocol can help hospital emergency department personnel more efficiently determine which patients with acute chest pain can be sent home safely, according to a randomized trial conducted at Wake Forest Baptist Medical Center.

16 Mar 2015

AcelRx announces dosing of first patient in pivotal ARX-04 Phase 3 study for treatment of acute pain

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain, today reported dosing of the first patient in the pivotal Phase 3 study of ARX-04.

16 Mar 2015

Egalet announces net revenues of $1.9 million for 2014

Egalet Corporation today reported financial results for the year ended December 31, 2014.

16 Mar 2015

Loyola's Bridget Boyd suggests ways to handle diaper rash

Diaper rash may not be a serious condition, but it can be extremely painful. It is common and causes concern for many parents trying to comfort their child.

16 Mar 2015

Results of pacritinib Phase 2 study in myelofibrosis patients published in journal 'Blood'

CTI BioPharma Corp. today announced that results of a Phase 2 study of pacritinib, in patients with myelofibrosis were published in the journal Blood. Pacritinib is a next-generation oral JAK2/FLT3 multikinase inhibitor currently in Phase 3 development in the PERSIST program.

16 Mar 2015

New NCCN Guidelines for Smoking Cessation published

Tobacco-related diseases are the most preventable cause of death worldwide; smoking cessation leads to improvement in cancer treatment outcomes, as well as decreased recurrence. According to the American Cancer Society, in 2015, nearly 171,000 of the estimated 589,430 cancer deaths in the United States--more than 25 percent--will be caused by tobacco smoking.

16 Mar 2015

BioSpecifics Technologies provides corporate update, reports Q4 and FY 2014 financial results

BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX® in the EU, today announced its financial results for the fourth quarter and full year ended December 31, 2014 and provided a corporate update.

13 Mar 2015

Researchers investigate effects of neuromodulatory medication on orofacial tissue

Today at the 93rd General Session and Exhibition of the International Association for Dental Research, researcher M.J. Al-Musawi, Newcastle University, Newcastle upon Tyne, UK, will present a study titled "In Vitro Effects of Topical Neuromodulatory Medication on Orofacial Tissue."

13 Mar 2015

Study compares HA injections and triamcinolone in improving pain in patients with lumbar ZJT arthropathy

A study presented at AAP 2015 San Antonio compares the effectiveness of HA injections to triamcinolone in improving pain and function in patients with lumbar ZJT arthropathy.

13 Mar 2015

Tablet use has implications for potential neck injury

Tablet use has rocketed. Last year in the US, for example, 42% of under 18's owned one and more than half of 35-49 year olds used them regularly.

13 Mar 2015

Loyola surgeon describes the immense benefits of minimally invasive spinal fusion surgery

A minimally invasive spinal fusion back surgery results in less blood loss, less postoperative pain, smaller incisions, a shorter hospital stay and faster recovery and return to work.

13 Mar 2015

Study shows fatigue pathways are more sensitive in patients with chronic fatigue syndrome

The mechanism that causes high-performance athletes to "feel the burn" turns out to be the culprit in what makes people with chronic fatigue syndrome feel exhausted by the most common daily activities, new University of Florida Health research shows.

13 Mar 2015

Study suggests distinct role of brain regions in dental pain relief

Today at the 93rd General Session and Exhibition of the International Association for Dental Research, researcher Michael L. Meier, Center for Dental Medicine, University of Zürich, Switzerland, will present a study titled "Distinct Brain Mechanisms Related to Dental Pain Relief."

13 Mar 2015

Scientists explore the potential genetic basis for loneliness

Loneliness may be a fundamental part of the human condition, but scientists have only recently begun exploring its causes, consequences, and potential interventions.

13 Mar 2015

The Medical Minute highlights risk and symptoms of IBD in children

Occasional stomach aches are part of life. But when they continue for more than a few weeks, come back often or are accompanied by bloody stools and additional symptoms, the cause could be inflammatory bowel disease, or IBD.

13 Mar 2015

JustRight Surgical obtains CE mark approval for FDA-cleared devices

JustRight Surgical, a micro-laparoscopic medical device company devoted to miniaturizing surgical instrumentation, has received CE mark approval for all of its FDA-cleared devices. CE marking indicates compliance with European Union regulations governing medical devices, no matter where in the world they are manufactured, and enables free movement within the European market.

12 Mar 2015

Houston Methodist Willowbrook Hospital recognized as one of 100 Top Hospitals in U.S.

Houston Methodist Willowbrook Hospital has been named one of the nation's 100 Top Hospitals by Truven Health Analytics, a leading provider of data-driven analytics and solutions to improve the cost and quality of healthcare.

12 Mar 2015

Oxis Biotech executes licensing agreement with MCIT for development of antibody-drug conjugates

Oxis Biotech, Inc., a wholly owned subsidiary of Oxis International, Inc., announced today the execution of a definitive licensing and development agreement with MultiCell Immunotherapeutics, Inc. concerning the development of certain antibody-drug conjugates (ADCs).

12 Mar 2015

Study finds that reformulated OxyContin forces some drug abusers to switch to heroin

A reformulation of OxyContin that makes it harder to abuse has curtailed the drug's illicit use. But some 25 percent of drug abusers entering rehab said they still abused the prescription painkiller despite package labeling that emphasizes its abuse-deterrent properties, new research indicates.

12 Mar 2015

Fourth patient dosed in Benitec Biopharma's Phase I/IIa hepatitis C trial

Benitec Biopharma, a biopharmaceutical company focused on providing potentially curative therapies with its proprietary gene-silencing technology called ddRNAi or "expressed RNAi," today announced that the fourth patient in the company's Phase I/IIa dose escalation clinical trial of its lead program TT-034 for treating hepatitis C was dosed at the Duke Clinical Research Unit.

11 Mar 2015

Pain News and Research

Latest Pain News and Research

New risk-evaluation protocol can help emergency departments evaluate chest-pain patients

AcelRx announces dosing of first patient in pivotal ARX-04 Phase 3 study for treatment of acute pain

Egalet announces net revenues of $1.9 million for 2014

Loyola's Bridget Boyd suggests ways to handle diaper rash

Results of pacritinib Phase 2 study in myelofibrosis patients published in journal 'Blood'

New NCCN Guidelines for Smoking Cessation published

BioSpecifics Technologies provides corporate update, reports Q4 and FY 2014 financial results

Researchers investigate effects of neuromodulatory medication on orofacial tissue

Study compares HA injections and triamcinolone in improving pain in patients with lumbar ZJT arthropathy

Tablet use has implications for potential neck injury

Loyola surgeon describes the immense benefits of minimally invasive spinal fusion surgery

Study shows fatigue pathways are more sensitive in patients with chronic fatigue syndrome

Study suggests distinct role of brain regions in dental pain relief

Scientists explore the potential genetic basis for loneliness

The Medical Minute highlights risk and symptoms of IBD in children

JustRight Surgical obtains CE mark approval for FDA-cleared devices

Houston Methodist Willowbrook Hospital recognized as one of 100 Top Hospitals in U.S.

Oxis Biotech executes licensing agreement with MCIT for development of antibody-drug conjugates

Study finds that reformulated OxyContin forces some drug abusers to switch to heroin

Fourth patient dosed in Benitec Biopharma's Phase I/IIa hepatitis C trial

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Pain News and Research

Latest Pain News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in